Microsaic Systems plc Distribution Agreement with Amedis, spol. s ro. (0483S)
June 21 2018 - 1:00AM
UK Regulatory
TIDMMSYS
RNS Number : 0483S
Microsaic Systems plc
21 June 2018
21 June 2018
Microsaic Systems plc
("Microsaic" or the "Company")
Distribution Agreement with Amedis, spol. s ro.
Microsaic Systems plc (AIM: MSYS), the developer of point of
need mass spectrometry ("MS") instruments, is pleased to announce
that it has signed a distribution agreement with Amedis, spol. s
ro. ("Amedis"). Amedis will be the exclusive distributor of
Microsaic-branded 4500 MiD(R) MS detectors in Slovakia.
Founded in 1991, Amedis distributes and provides application and
service support for global brands across a wide range of
technologies, including Liquid Chromatography Mass Spectrometry
("LCMS"), Inductively Coupled Plasma Mass Spectrometry ("ICPMS"),
Gas Chromatography Mass Spectrometry ("GCMS") and Nuclear Magnetic
Resonance ("NMR"). Additionally, Amedis has expertise in medical
technologies, such as Linear Accelerators, Medical Imaging and
Dosimetry for Radiation Therapy.
Glenn Tracey, CEO of Microsaic, commented, "Amedis is the
perfect partner to distribute our compact, point of need MS
technology, already having an impressive technology portfolio,
unrivaled technical expertise, and full understanding of end user
applications.
"Central Europe has shown impressive growth and opportunity for
scientific instrumentation in recent years, and this agreement
supports our growth strategy with select partners across the
European region."
Milos Sebedinsky, CEO of Amedis, added: "Amedis appreciates the
possibility to widen its product portfolio with the top quality
Microsaic product range, especially in the field of flash
chromatography purification. Our plan also is to integrate 4500
MiD(R) with High Performance Liquid Chromatography systems we are
selling, as a complement to other detectors."
Enquiries:
Microsaic Systems plc
Glenn Tracey, CEO
Bevan Metcalf, FD +44 (0) 1483 751 577
N+1 Singer (Nominated Adviser &
Broker)
Shaun Dobson
Liz Yong +44 (0)20 7496 3000
IFC Advisory Ltd (Financial PR)
Graham Herring
Heather Armstrong
Florence Chandler +44 (0)20 3934 6630
About Microsaic Systems
Microsaic Systems plc (AIM: MSYS) is a high technology company
developing chip-based, bench-top and point-of-analysis mass
spectrometry ("MS") instruments that are designed to improve the
efficiency of pharmaceutical R&D and manufacturing. The Company
is working with established global life science companies to
co-develop new solutions to improve productivity in the development
of small molecule and novel biologic (peptides, antibodies)
medicines. MS is a powerful method of analysis to enable earlier
decision making relating to product identification, purity and
bioactivity, and is the analytical technique of choice for
biochemists across many industry sectors.
Microsaic's core product, the 4500 MiD(R), is a robust and
compact MS system, retaining the functionality of larger
conventional MS systems, is easier to use by non-specialists,
consumes less energy and has lower running costs. For more
information, please go to www.microsaic.com.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
AGRLLFVERSIIFIT
(END) Dow Jones Newswires
June 21, 2018 02:00 ET (06:00 GMT)
Microsaic Systems (LSE:MSYS)
Historical Stock Chart
From Apr 2024 to May 2024
Microsaic Systems (LSE:MSYS)
Historical Stock Chart
From May 2023 to May 2024